Photodynamic therapy induces an immune response against a bacterial pathogen

Expert Review of Clinical Immunology

Volumn 8, Issue 5, 2012, Pages 479-494

  Huang, Ying Ying ^a,b,c   Tanaka, Masamitsu ^a,b,d   Vecchio, Daniela ^a,b   Garcia Diaz, Maria ^a,e   Chang, Julie ^a,f   Morimoto, Yuji ^d   Hamblin, Michael R ^a,b,g  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GUANGXI MEDICAL UNIVERSITY   (China)

^d NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^e INSTITUT QUÍMIC DE SARRIÀ   (Spain)

^f HARVARD UNIVERSITY   (United States)

^g HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

bacterial arthritis; bioluminescence imaging; methicillin resistant Staphylococcus aureus; methylene blue; neutrophils; photodynamic therapy; Photofrin ; preventative PDT

Indexed keywords

ACRIDINE; ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; AZURE B; BENZOPORPHYRIN DERIVATIVE; CRYSTAL VIOLET; CYCLOPHOSPHAMIDE; ERYTHROSINE; FULLERENE DERIVATIVE; IMMUNOSTIMULATING AGENT; METHYLENE BLUE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PORPHYRIN DERIVATIVE; ROSE BENGAL; TALAPORFIN; TETRAHYDROPORPHYRIN TETRATOSYLATE; TOLONIUM CHLORIDE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; BACTERIAL ARTHRITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BASAL CELL CARCINOMA; BIOLUMINESCENCE; CANCER THERAPY; COMBINATION CHEMOTHERAPY; CYTOTOXICITY; DOSE RESPONSE; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INNATE IMMUNITY; LASER; LOW DRUG DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEUTROPHIL; NONHUMAN; PHOTODYNAMIC THERAPY; REVIEW; THERAPY EFFECT; TREATMENT RESPONSE; TUMOR IMMUNITY;

ANIMALS; ARTHRITIS, INFECTIOUS; DIHEMATOPORPHYRIN ETHER; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; NEUTROPHILS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; STAPHYLOCOCCAL INFECTIONS;

EID: 84865012223     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.37     Document Type: Review

References (142)

1. Hamblin MR, Mroz P, History of PDT - the first hundred years. In: Advances in Photodynamic Therapy: Basic, Translational and Clinical. MR Hamblin, P Mroz (Eds). Artech House, MA, USA, 1-12 (2008
2. Agostinis P, Berg K, Cengel KA et al. Photodynamic therapy of cancer: An update. CA Cancer J. Clin. 61(4), 250-281 (2011
3. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J. Photochem. Photobiol. B. Biol. 39(1), 1-18 (1997
4. St Denis TG, Dai T, Izikson L et al. All you need is light: Antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence 2(6), 509-520 (2011
5. Hamblin MR, Hasan T. Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 3(5), 436-450 (2004
6. Hamblin MR, Jori G. Photodynamic inactivation of microbial pathogens: Medical and environmental applications. In: Comprehensive Series in Photochemical and Photobiological Sciences. GP Hader, G Jori (Eds). RSC Publishing, Cambridge, UK (2011
7. Sharma SK, Dai T, Kharkwal GB et al. Drug discovery of antimicrobial photosensitizers using animal models. Curr. Pharm. Des. 17(13), 1303-1319 (2011
8. Dai T, Huang YY, Hamblin MR. Photodynamic therapy for localized infections - state of the art. Photodiagnosis Photodyn. Ther. 6(3-4), 170-188 (2009
9. Kharkwal GB, Sharma SK, Huang YY, Dai T, Hamblin MR. Photodynamic therapy for infections: Clinical applications. Lasers Surg. Med. 43(7), 755-767 (2011
10. Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 6(7), 535-545 (2006
11. Mroz P, Hashmi JT, Huang YY, Lange N, Hamblin MR. Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev. Clin. Immunol. 7(1), 75-91 (2011
12. St Denis TG, Aziz K, Waheed AA et al. Combination approaches to potentiate immune response after photodynamic therapy for cancer. Photochem. Photobiol. Sci. 10(5), 792-801 (2011
13. Dougherty TJ, Gomer CJ, Henderson BW et al. Photodynamic therapy. J. Natl Cancer Inst. 90(12), 889-905 (1998
14. Gollnick SO, Owczarczak B, Maier P. Photodynamic therapy and anti-tumor immunity. Lasers Surg. Med. 38(5), 509-515 (2006
15. Bianchi ME. DAMPs, PAMPs and alarmins: All we need to know about danger. J. Leukoc. Biol. 81(1), 1-5 (2007
16. Garg AD, Nowis D, Golab J, Vandenabeele P, Krysko DV, Agostinis P. Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation. Biochim. Biophys. Acta 1805(1), 53-71 (2010
17. Garg AD, Nowis D, Golab J, Agostinis P. Photodynamic therapy: Illuminating the road from cell death towards anti-tumour immunity. Apoptosis 15(9), 1050-1071 (2010
18. Garg AD, Krysko DV, Vandenabeele P, Agostinis P. DAMPs and PDT-mediated photo-oxidative stress: Exploring the unknown. Photochem. Photobiol. Sci. 10(5), 670-680 (2011
19. Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: Relevance for tumor response. Cancer Res. 65(3), 1018-1026 (2005
20. Gomer CJ, Ryter SW, Ferrario A, Rucker N, Wong S, Fisher AM. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. Cancer Res. 56(10), 2355-2360 (1996
21. Chun KH, Seong SY. CD14 but not MD2 transmit signals from DAMP. Int. Immunopharmacol. 10(1), 98-106 (2010
22. Lee KM, Seong SY. Partial role of TLR4 as a receptor responding to damage-associated molecular pattern. Immunol. Lett. 125(1), 31-39 (2009
23. Cecic I, Parkins CS, Korbelik M. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors. Photochem. Photobiol. 74(5), 712-720 (2001
24. Cecic I, Stott B, Korbelik M. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int. Immunopharmacol. 6(8), 1259-1266 (2006
25. Krosl G, Korbelik M, Dougherty GJ. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. Br. J. Cancer 71(3), 549-555 (1995
26. de Vree WJ, Essers MC, de Bruijn HS, Star WM, Koster JF, Sluiter W. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res. 56(13), 2908-2911 (1996
27. Cecic I, Korbelik M. Deposition of complement proteins on cells treated by photodynamic therapy in vitro. J. Environ. Pathol. Toxicol. Oncol. 25(1-2), 189-203 (2006
28. Korbelik M, Cecic I. Complement activation cascade and its regulation: Relevance for the response of solid tumors to photodynamic therapy. J. Photochem. Photobiol. B. Biol. 93(1), 53-59 (2008
29. Li F, Cheng Y, Lu J, Hu R, Wan Q, Feng H. Photodynamic therapy boosts anti-glioma immunity in mice: A dependence on the activities of T cells and complement C3. J. Cell. Biochem. 112(10), 3035-3043 (2011
30. Steubing RW, Yeturu S, Tuccillo A, Sun CH, Berns MW. Activation of macrophages by Photofrin II during photodynamic therapy. J. Photochem. Photobiol. B. Biol. 10(1-2), 133-145 (1991
31. Evans S, Matthews W, Perry R, Fraker D, Norton J, Pass HI. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J. Natl Cancer Inst. 82(1), 34-39 (1990
32. Zhou F, Xing D, Chen WR. Regulation of HSP70 on activating macrophages using PDT-induced apoptotic cells. Int. J. Cancer 125(6), 1380-1389 (2009
33. Korbelik M, Krosl G. Enhanced macrophage cytotoxicity against tumor cells treated with photodynamic therapy. Photochem. Photobiol. 60(5), 497-502 (1994
34. Preise D, Oren R, Glinert I et al. Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunol. Immunother. 58(1), 71-84 (2009
35. Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res. 62(6), 1604-1608 (2002
36. Kushibiki T, Tajiri T, Tomioka Y, Awazu K. Photodynamic therapy induces interleukin secretion from dendritic cells. Int. J. Clin. Exp. Med. 3(2), 110-114 (2010
37. Etminan N, Peters C, Lakbir D et al. Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro. Br. J. Cancer 105(7), 961-969 (2011
38. Kabingu E, Vaughan L, Owczarczak B, Ramsey KD, Gollnick SO. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. Br. J. Cancer 96(12), 1839-1848 (2007
39. Hendrzak-Henion JA, Knisely TL, Cincotta L, Cincotta E, Cincotta AH. Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy. Photochem. Photobiol. 69(5), 575-581 (1999
40. Canti G, Lattuada D, Nicolin A, Taroni P, Valentini G, Cubeddu R. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Anticancer. Drugs 5(4), 443-447 (1994
41. Korbelik M, Dougherty GJ. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res. 59(8), 1941-1946 (1999
42. Belicha-Villanueva A, Riddell J, Bangia N, Gollnick SO. The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules. Lasers Surg. Med. 44(1), 60-68 (2012
43. Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int. J. Cancer 127(4), 759-767 (2010
44. Castano AP, Mroz P, Wu MX, Hamblin MR. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc. Natl Acad. Sci. USA 105(14), 5495-5500 (2008
45. Mroz P, Hamblin MR. The immunosuppressive side of PDT. Photochem. Photobiol. Sci. 10(5), 751-758 (2011
46. Matthews YJ, Damian DL. Topical photodynamic therapy is immunosuppressive in humans. Br. J. Dermatol. 162(3), 637-641 (2010
47. Hayami J, Okamoto H, Sugihara A, Horio T. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid. J. Dermatol. 34(5), 320-327 (2007
48. Hunt DW, Levy JG. Immunomodulatory aspects of photodynamic therapy. Expert Opin. Investig. Drugs 7(1), 57-64 (1998
49. Hunt DW, Jiang H, Granville DJ, Chan AH, Leong S, Levy JG. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. Immunopharmacology 41(1), 31-44 (1999
50. Boumédine RS, Roy DC. Elimination of alloreactive T cells using photodynamic therapy. Cytotherapy 7(2), 134-143 (2005
51. Lavie G, Meruelo D, Aroyo K, Mandel M. Inhibition of the CD8+ T cell-mediated cytotoxicity reaction by hypericin: Potential for treatment of T cell-mediated diseases. Int. Immunol. 12(4), 479-486 (2000
52. Favre L, Borle F, Velin D et al. Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis. Endoscopy 43(7), 604-616 (2011
53. Rook AH, Wood GS, Duvic M, Vonderheid EC, Tobia A, Cabana B. A Phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis. J. Am. Acad. Dermatol. 63(6), 984-990 (2010
54. Korbelik M, Krosl G, Krosl J, Dougherty GJ. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res. 56(24), 5647-5652 (1996
55. Castano AP, Liu Q, Hamblin MR. A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy. Br. J. Cancer 94(3), 391-397 (2006
56. Mroz P, Szokalska A, Wu MX, Hamblin MR. Photodynamic therapy of tumors can lead to development of systemic antigenspecific immune response. PLoS ONE 5(12), e15194 (2010
57. Kabingu E, Oseroff AR, Wilding GE, Gollnick SO. Enhanced systemic immune reactivity to a basal cell carcinoma associated antigen following photodynamic therapy. Clin. Cancer Res. 15(13), 4460-4466 (2009
58. Thong PS, Olivo M, Kho KW et al. Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy. J. Environ. Pathol. Toxicol. Oncol. 27(1), 35-42 (2008
59. Thong PS, Ong KW, Goh NS et al. Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. Lancet Oncol. 8(10), 950-952 (2007
60. Canti G, Calastretti A, Bevilacqua A, Reddi E, Palumbo G, Nicolin A. Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia. Neoplasma 57(2), 184-188 (2010
61. Uehara M, Sano K, Wang ZL, Sekine J, Ikeda H, Inokuchi T. Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma. Cancer Immunol. Immunother. 49(8), 401-409 (2000
62. Myers RC, Lau BH, Kunihira DY, Torrey RR, Woolley JL, Tosk J. Modulation of hematoporphyrin derivative-sensitized phototherapy with Corynebacterium parvum in murine transitional cell carcinoma. Urology 33(3), 230-235 (1989
63. Korbelik M. Cancer vaccines generated by photodynamic therapy. Photochem. Photobiol. Sci. 10(5), 664-669 (2011
64. Gollnick SO, Brackett CM. Enhancement of anti-tumor immunity by photodynamic therapy. Immunol. Res. 46(1-3), 216-226 (2010
65. Allaire S, Wolfe F, Niu J, Lavalley MP. Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US. Arthritis Rheum. 59(4), 474-480 (2008
66. Lacaille D. Arthritis and employment research: where are we? Where do we need to go? J. Rheumatol. Suppl. 72, 42-45 (2005
67. Beischer AD, Bhathal P, de Steiger R, Penn D, Stylli S. Synovial ablation in a rabbit rheumatoid arthritis model using photodynamic therapy. ANZ J. Surg. 72(7), 517-522 (2002
68. Trauner KB, Hasan T. Photodynamic treatment of rheumatoid and inflammatory arthritis. Photochem. Photobiol. 64(5), 740-750 (1996
69. Peacock DJ, Banquerigo ML, Brahn E. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. Cell. Immunol. 160(2), 178-184 (1995
70. Ratkay LG, Chowdhary RK, Neyndorff HC, Tonzetich J, Waterfield JD, Levy JG. Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL-lpr mice. Clin. Exp. Immunol. 95(3), 373-377 (1994
71. Trauner KB, Gandour-Edwards R, Bamberg M, Shortkroff S, Sledge C, Hasan T. Photodynamic synovectomy using benzoporphyrin derivative in an antigeninduced arthritis model for rheumatoid arthritis. Photochem. Photobiol. 67(1), 133-139 (1998
72. Ratkay LG, Chowdhary RK, Iamaroon A et al. Amelioration of antigen-induced arthritis in rabbits by induction of apoptosis of inflammatory cells with local application of transdermal photodynamic therapy. Arthritis Rheum. 41(3), 525-534 (1998
73. Chowdhary RK, Ratkay LG, Canaan AJ, Waterfield JD, Richter AM, Levy JG. Uptake of verteporfin by articular tissues following systemic and intra-articular administration. Biopharm. Drug Dispos. 19(6), 395-400 (1998
74. Funke B, Jungel A, Schastak S, Wiedemeyer K, Emmrich F, Sack U. Transdermal photodynamic therapy-a treatment option for rheumatic destruction of small joints? Lasers Surg. Med. 38(9), 866-874 (2006
75. Oertel M, Schastak SI, Tannapfel A et al. Novel bacteriochlorine for high tissuepenetration: Photodynamic properties in human biliary tract cancer cells in vitro and in a mouse tumour model. J. Photochem. Photobiol. B. Biol. 71(1-3), 1-10 (2003
76. Schastak S, Jean B, Handzel R et al. Improved pharmacokinetics, biodistribution and necrosis in vivo using a new near infra-red photosensitizer: Tetrahydroporphyrin tetratosylat. J. Photochem. Photobiol. B. Biol. 78(3), 203-213 (2005
77. Anderson RR, Parrish JA. The optics of human skin. J. Invest. Dermatol. 77(1), 13-19 (1981
78. Torikai E, Kageyama Y, Kohno E et al. Photodynamic therapy using talaporfin sodium for synovial membrane from rheumatoid arthritis patients and collageninduced arthritis rats. Clin. Rheumatol. 27(6), 751-761 (2008
79. Taber SW, Fingar VH, Coots CT, Wieman TJ. Photodynamic therapy using mono-laspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: A Phase I clinical study. Clin. Cancer Res. 4(11), 2741-2746 (1998
80. Nakamura H, Suzuki Y, Takeichi M, Saito T, Takayama M, Aizawa K. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-l-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines. Int. J. Gynecol. Cancer 12(2), 177-186 (2002
81. Mori K, Yoneya S, Anzail K et al. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: Mono-l-aspartyl chlorin e6. Retina (Philadelphia, Pa) 21(5), 499-508 (2001
82. Nagae T, Aizawa K, Uchimura N et al. Endovascular photodynamic therapy using mono-l-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries. Lasers Surg. Med. 28(4), 381-388 (2001
83. Kato H, Furukawa K, Sato M et al. Phase II clinical study of photodynamic therapy using mono-l-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 42(1), 103-111 (2003
84. Nitzan Y, Gutterman M, Malik Z, Ehrenberg B. Inactivation of Gramnegative bacteria by photosensitized porphyrins. Photochem. Photobiol. 55(1), 89-96 (1992
85. Malik Z, Ladan H, Nitzan Y. Photodynamic inactivation of Gram-negative bacteria: Problems and possible solutions. J. Photochem. Photobiol. B. Biol. 14(3), 262-266 (1992
86. Minnock A, Vernon DI, Schofield J, Griffiths J, Parish JH, Brown SB. Mechanism of uptake of a cationic water-soluble pyridinium zinc phthalocyanine across the outer membrane of Escherichia coli. Antimicrob. Agents Chemother. 44(3), 522-527 (2000
87. Valduga G, Bertoloni G, Reddi E, Jori G. Effect of extracellularly generated singlet oxygen on Gram-positive and Gramnegative bacteria. J. Photochem. Photobiol. B. Biol. 21(1), 81-86 (1993
88. Tegos GP, Demidova TN, Arcila-Lopez D et al. Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem. Biol. 12(10), 1127-1135 (2005
89. Mohr H, Lambrecht B, Selz A. Photodynamic virus inactivation of blood components. Immunol. Invest. 24(1-2), 73-85 (1995
90. Kassab K, Ben Amor T, Jori G, Coppellotti O. Photosensitization of Colpoda inflata cysts by meso-substituted cationic porphyrins. Photochem. Photobiol. Sci. 1(8), 560-564 (2002
91. Demidova TN, Hamblin MR. Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl. Environ. Microbiol. 71(11), 6918-6925 (2005
92. Ferro S, Coppellotti O, Roncucci G, Ben Amor T, Jori G. Photosensitized inactivation of Acanthamoeba palestinensis in the cystic stage. J. Appl. Microbiol. 101(1), 206-212 (2006
93. Jori G, Fabris C, Soncin M et al. Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications. Lasers Surg. Med. 38(5), 468-481 (2006
94. Harris F, Chatfield LK, Phoenix DA. Phenothiazinium based photosensitisers- photodynamic agents with a multiplicity of cellular targets and clinical applications. Curr. Drug Targets 6(5), 615-627 (2005
95. Huang L, Huang YY, Mroz P et al. Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob. Agents Chemother. 54(9), 3834-3841 (2010
96. Kuznetsova N, Makarov D, Yuzhakova O et al. Photophysical properties and photodynamic activity of octacationic oxotitanium(IV) phthalocyanines. Photochem. Photobiol. Sci. 8(12), 1724-1733 (2009
97. Usacheva MN, Teichert MC, Biel MA. The role of the methylene blue and toluidine blue monomers and dimers in the photoinactivation of bacteria. J. Photochem. Photobiol. B, Biol. 71(1-3), 87-98 (2003
98. Usacheva MN, Teichert MC, Biel MA. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against Gram-positive and Gram-negative microorganisms. Lasers Surg. Med. 29(2), 165-173 (2001
99. Wainwright M. Methylene blue derivatives - suitable photoantimicrobials for blood product disinfection? Int. J. Antimicrob. Agents 16(4), 381-394 (2000
100. Wainwright M, Phoenix DA, Laycock SL, Wareing DR, Wright PA. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol. Lett. 160(2), 177-181 (1998
101. Lazzeri D, Rovera M, Pascual L, Durantini EN. Photodynamic studies and photoinactivation of Escherichia coli using meso-substituted cationic porphyrin derivatives with asymmetric charge distribution. Photochem. Photobiol. 80(2), 286-293 (2004
102. Maisch T, Bosl C, Szeimies RM, Lehn N, Abels C. Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob. Agents Chemother. 49(4), 1542-1552 (2005
103. Segalla A, Borsarelli CD, Braslavsky SE et al. Photophysical, photochemical and antibacterial photosensitizing properties of a novel octacationic Zn(II)-phthalocyanine. Photochem. Photobiol. Sci. 1(9), 641-648 (2002
104. Kussovski V, Mantareva V, Angelov I et al. Photodynamic inactivation of Aeromonas hydrophila by cationic phthalocyanines with different hydrophobicity. FEMS Microbiol. Lett. 294(2), 133-140 (2009
105. Simonetti O, Cirioni O, Orlando F et al. Effectiveness of antimicrobial photodynamic therapy with a single treatment of RLP068/ Cl in an experimental model of Staphylococcus aureus wound infection. Br. J. Dermatol. 164(5), 987-995 (2011
106. Gad F, Zahra T, Francis KP, Hasan T, Hamblin MR. Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem. Photobiol. Sci. 3(5), 451-458 (2004
107. Teichert MC, Jones JW, Usacheva MN, Biel MA. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 93(2), 155-160 (2002
108. Hamblin MR, Zahra T, Contag CH, McManus AT, Hasan T. Optical monitoring and treatment of potentially lethal wound infections in vivo. J. Infect. Dis. 187(11), 1717-1725 (2003
109. Wong TW, Wang YY, Sheu HM, Chuang YC. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob. Agents Chemother. 49(3), 895-902 (2005
110. Zolfaghari PS, Packer S, Singer M et al. In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent. BMC Microbiol. 9, 27 (2009
111. Hamblin MR, O'Donnell DA, Murthy N, Contag CH, Hasan T. Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem. Photobiol. 75(1), 51-57 (2002
112. Dai T, Tegos GP, Lu Z et al. Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob. Agents Chemother. 53(9), 3929-3934 (2009
113. Lambrechts SA, Demidova TN, Aalders MC, Hasan T, Hamblin MR. Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem. Photobiol. Sci. 4(7), 503-509 (2005
114. Shibli JA, Martins MC, Nociti FH Jr, Garcia VG, Marcantonio E Jr. Treatment of ligature-induced peri-implantitis by lethal photosensitization and guided bone regeneration: A preliminary histologic study in dogs. J. Periodontol. 74(3), 338-345 (2003
115. Kömerik N, Nakanishi H, MacRobert AJ, Henderson B, Speight P, Wilson M. In vivo killing of Porphyromonas gingivalis by toluidine blue-mediated photosensitization in an animal model. Antimicrob. Agents Chemother. 47(3), 932-940 (2003
116. Fernandes LA, de Almeida JM, Theodoro LH et al. Treatment of experimental periodontal disease by photodynamic therapy in immunosuppressed rats. J. Clin. Periodontol. 36(3), 219-228 (2009
117. de Almeida JM, Theodoro LH, Bosco AF, Nagata MJ, Bonfante S, Garcia VG. Treatment of experimental periodontal disease by photodynamic therapy in rats with diabetes. J. Periodontol. 79(11), 2156-2165 (2008
118. de Almeida JM, Theodoro LH, Bosco AF, Nagata MJ, Oshiiwa M, Garcia VG. Influence of photodynamic therapy on the development of ligature-induced periodontitis in rats. J. Periodontol. 78(3), 566-575 (2007
119. Berthiaume F, Reiken SR, Toner M, Tompkins RG, Yarmush ML. Antibodytargeted photolysis of bacteria in vivo. Biotechnology (NY) 12(7), 703-706 (1994
120. Smetana Z, Malik Z, Orenstein A, Mendelson E, Ben-Hur E. Treatment of viral infections with 5-aminolevulinic acid and light. Lasers Surg. Med. 21(4), 351-358 (1997
121. Moore C, Wallis C, Melnick JL, Kuns MD. Photodynamic treatment of herpes keratitis. Infect. Immun. 5(2), 169-171 (1972
122. Gardlo K, Horska Z, Enk CD et al. Treatment of cutaneous leishmaniasis by photodynamic therapy. J. Am. Acad. Dermatol. 48(6), 893-896 (2003
123. Sohl S, Kauer F, Paasch U, Simon JC. Photodynamic treatment of cutaneous leishmaniasis. J. Dtsch Dermatol. Ges. 5(2), 128-130 (2007
124. González U, Pinart M, Reveiz L, Alvar J. Interventions for old world cutaneous leishmaniasis. Cochrane Database Syst. Rev. 4, CD005067 (2008
125. Maisch T, Baier J, Franz B et al. The role of singlet oxygen and oxygen concentration in photodynamic inactivation of bacteria. Proc. Natl Acad. Sci. USA 104(17), 7223-7228 (2007
126. Tanaka M, Kinoshita M, Yoshihara Y et al. Influence of intra-articular neutrophils on the effects of photodynamic therapy for murine MRSA arthritis. Photochem. Photobiol. 86(2), 403-409 (2010
127. Hamblin MR, Dai T. Can surgical site infections be treated by photodynamic therapy? Photodiagnosis Photodyn. Ther. 7(2), 134-136 (2010
128. Tanaka M, Kinoshita M, Yoshihara Y et al. Photodynamic therapy using intra-articular Photofrin for murine MRSA arthritis: Biphasic light dose response for neutrophilmediated antibacterial effect. Lasers Surg. Med. 43(3), 221-229 (2011
129. Tanaka M, Kinoshita M, Yoshihara Y et al. Optimal photosensitizers for photodynamic therapy of infections should kill bacteria but spare neutrophils. Photochem. Photobiol. 88(1), 227-232 (2012
130. Wood S, Metcalf D, Devine D, Robinson C. Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J. Antimicrob. Chemother. 57(4), 680-684 (2006
131. Docampo R, Moreno SN, Muniz RP, Cruz FS, Mason RP. Light-enhanced free radical formation and trypanocidal action of gentian violet (crystal violet). Science 220(4603), 1292-1295 (1983
132. Kato H, Usuda J, Okunaka T et al. Basic and clinical research on photodynamic therapy at Tokyo Medical University Hospital. Lasers Surg. Med. 38(5), 371-375 (2006
133. Tseng SP, Teng LJ, Chen CT et al. Toluidine blue O photodynamic inactivation on multidrug-resistant Pseudomonas aeruginosa. Lasers Surg. Med. 41(5), 391-397 (2009
134. Hirao A, Sato S, Saitoh D, Shinomiya N, Ashida H, Obara M. In vivo photoacoustic monitoring of photosensitizer distribution in burned skin for antibacterial photodynamic therapy. Photochem. Photobiol. 86(2), 426-430 (2010
135. Renkin EM. Cellular and intercellular transport pathways in exchange vessels. Am. Rev. Respir. Dis. 146(5 Pt 2), S28-S31 (1992
136. König K, Bockhorn V, Dietel W, Schubert H. Photochemotherapy of animal tumors with the photosensitizer methylene blue using a krypton laser. J. Cancer Res. Clin. Oncol. 113(3), 301-303 (1987
137. Tanaka M, Mroz P, Dai T, Huang L, Morimoto Y et al. Photodynamic therapy can induce a protective innate immune response against murine bacterial arthritis via neutrophil accumulation. PLoS ONE 7(6), e39823 (2012
138. Dai T, Tegos GP, Zhiyentayev T, Mylonakis E, Hamblin MR. Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers Surg. Med. 42(1), 38-44 (2010
139. Cecic I, Korbelik M. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett. 183(1), 43-51 (2002
140. Montefort S, Gratziou C, Goulding D et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyteendothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J. Clin. Invest. 93(4), 1411-1421 (1994
141. Kielian T, Hickey WF. Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development. Am. J. Pathol. 157(2), 647-658 (2000
142. Sun YX, Dai DK, Liu R et al. Therapeutic effect of SN50, an inhibitor of nuclear factor-?B, in treatment of TBI in mice. Neurol. Sci. doi:10.1007/s10072-012-1007-z (2012) (Epub ahead of print